Related Experiment Video
Updated: Sep 2, 2025
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
9.3K
The interactions that shape amyloid fibrils in disease
1Department of Biochemistry, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Structure (London, England : 1993)
|August 5, 2022
Summary
Researchers used computational methods to study amyloid fibril assembly. They found that specific protein regions predisposed to cross-beta conformation drive fibril formation, while other regions may cause structural diversity.
Area of Science:
- Biochemistry
- Structural Biology
- Computational Biology
Background:
- Amyloid fibrils are protein aggregates implicated in various diseases.
- The structural basis of amyloid formation and polymorphism remains incompletely understood.
Purpose of the Study:
- To computationally investigate the key determinants of protein assembly into amyloid fibrils.
- To understand the structural basis of amyloid polymorphism.
Main Methods:
- Utilized a computational approach to analyze protein sequences and structures.
- Examined the propensity of amino acid residues for cross-beta conformation.
Main Results:
- Identified that approximately 30% of residues in structurally distinct amyloids are predisposed to cross-beta conformation.
- Less favorable regions within amyloidogenic proteins may interact with cofactors, contributing to polymorphism.
Conclusions:
- The inherent propensity of specific protein regions for cross-beta structure is a primary driver of amyloid fibril assembly.
- Protein regions with lower propensity for cross-beta conformation can influence fibril structure diversity through cofactor interactions.
Related Concept Videos
03:03Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
01:26Alzheimer's Disease: Overview
659
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
659
01:22Alzheimer's Disease: Treatment
256
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
256
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
262
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
262
01:25Protein Folding
8.4K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
8.4K